Using the exact same model of DIO mice having undergone continuous subcutaneous ANP treatment [6], we recently reported that exogenous ANP treatment ameliorates systemic insulin resistance by attenuating hepatic steatosis and inducing adipose tissue browning in association with the activation of the brown fat thermogenic program. Here, NPPA is linked to fatty liver disease.